Showing 1 - 20 results of 44 for search 'Stephen M Ansell', query time: 0.06s
Refine Results
-
1
Maintaining Efficacy But Decreasing Toxicity in the Treatment of Hodgkin Lymphoma by Stephen M. Ansell
Published 2017-12-01
Article -
2
Modulation of T-cell function by myeloid-derived suppressor cells in hematological malignancies by Vaishali Bhardwaj, Stephen M. Ansell
Published 2023-04-01
Article -
3
CAR T-cells: Driving in the Fast Lane by Stephen M. Ansell, Paolo Corradini
Published 2019-06-01
Article -
4
Activating the Antitumor Immune Response in Non-Hodgkin Lymphoma Using Immune Checkpoint Inhibitors by Maansi Joshi, Stephen M. Ansell
Published 2020-01-01
Article -
5
Unraveling the role of cancer-associated fibroblasts in B cell lymphoma by Prithviraj Mukherjee, Stephen M. Ansell, Patrizia Mondello
Published 2024-11-01
Article -
6
Insights into the tumor microenvironment of B cell lymphoma by Wern Lynn Ng, Stephen M. Ansell, Patrizia Mondello
Published 2022-12-01
Article -
7
Advances in CD30- and PD-1-targeted therapies for classical Hodgkin lymphoma by Yucai Wang, Grzegorz S. Nowakowski, Michael L. Wang, Stephen M. Ansell
Published 2018-04-01
Article -
8
-
9
Interleukin-15 Affects Patient Survival through Natural Killer Cell Recovery after Autologous Hematopoietic Stem Cell Transplantation for Non-Hodgkin Lymphomas by Luis F. Porrata, David J. Inwards, Ivana N. Micallef, Patrick B. Johnston, Stephen M. Ansell, William J. Hogan, Svetomir N. Markovic
Published 2010-01-01
Article -
10
Day 100 Recovery of Absolute Number of Inhibitory KIR2DL2 and Activating NKp30 Natural Killer Cells Predicts Survival Post-Autologous Stem Cell Transplantation in Lymphomas by Luis F. Porrata, Stephen M. Ansell, Ivana N. Micallef, Patrick B. Johnston, Jose C. Villasboas, Jonas Paludo, Urshila Durani, Svetomir N. Markovic
Published 2024-08-01
Article -
11
-
12
Expression of KLRG1 and CD127 defines distinct CD8+ subsets that differentially impact patient outcome in follicular lymphoma by Hyo Jin Kim, Stephen M Ansell, Hongyan Wu, Anne J Novak, Xinyi Tang, Shahrzad Jalali, Joshua C Pritchett, Jose C Villasboas, Zhi-Zhang Yang
Published 2021-07-01
Article -
13
End-of-treatment PET in early-stage Hodgkin lymphoma: valuable in addition to interim PET by Karan L. Chohan, Jason R. Young, Scott Lester, Muhamad Alhaj Moustafa, Allison Rosenthal, Han W. Tun, Bradford S. Hoppe, Patrick B. Johnston, Ivana N. Micallef, Thomas M. Habermann, Stephen M. Ansell
Published 2022-12-01
Article -
14
Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immunotherapy for the treatment of lymphoma by Ronald Levy, Joshua Brody, David L Porter, Sattva S Neelapu, Koen Van Besien, Michael Werner, Michael R Bishop, Mitchell S Cairo, Sherry Adkins, Stephen M Ansell, Jonathan W Friedberg, Justin P Kline
Published 2020-10-01
Article -
15
T100: Long term Follow-up of a Phase I Study Combinations of Ipilimumab, Nivolumab and Brentuximab Vedotin in Patients with Relapsed/Refractory Hodgkin Lymphoma: A trial of the ECO... by Catherine Diefenbach, Opeyemi Jegede, Richard Ambinder, Jonathon Cohen, Michael Robertson, Kevin David, Ranjana Advani, Timothy Fenske, Stefan Barta, Neil Palmisiano, Jakub Svoboda, David Morgan, Reem Karmali, Brad Kahl, Stephen M. Ansell
Published 2022-10-01
Article -
16
Baseline echocardiographic variables as predictors of hemodynamically significant cytokine release syndrome in adults treated with CD19 CAR T-cell therapy for hematological maligna... by Andres E. Daryanani, Muhannad A. Abbasi, Maria F. Gomez Ardila, Eduardo Tellez-Garcia, Juan M. Garzon-Dangond, Yi Lin, Jonas Paludo, Joerg Herrmann, Stephen M. Ansell, Allison C. Rosenthal, Hector R. Villarraga
Published 2024-12-01
Article -
17
Peripheral blood lymphocyte/monocyte ratio at diagnosis and survival in classical Hodgkin’s lymphoma by Luis F. Porrata, Kay Ristow, Joseph P. Colgan, Thomas M. Habermann, Thomas E. Witzig, David J. Inwards, Stephen M. Ansell, Ivana N. Micallef, Patrick B. Johnston, Grzegorz S. Nowakowski, Carrie Thompson, Svetomir N. Markovic
Published 2012-02-01
Article -
18
Procalcitonin as a biomarker for predicting bacterial infection in chimeric antigen receptor T‐cell therapy recipients by Marissa Z. Powell, Kristin C. Mara, Radhika Bansal, Matthew A. Hathcock, Arushi Khurana, N. Nora Bennani, Yucai Wang, Jonas Paludo, Jose Villasboas Bisneto, Stephen M. Ansell, Patrick B. Johnston, Yi Lin, Jason N. Barreto
Published 2023-04-01
Article -
19
Expanded tumor-associated polymorphonuclear myeloid-derived suppressor cells in Waldenstrom macroglobulinemia display immune suppressive activity by Vaishali Bhardwaj, Zhi-Zhang Yang, Shahrzad Jalali, Jose C. Villasboas, Rekha Mudappathi, Junwen Wang, Prithviraj Mukherjee, Jonas Paludo, Xinyi Tang, Hyo Jin Kim, Jordan E. Krull, Kerstin Wenzl, Anne J. Novak, Patrizia Mondello, Stephen M. Ansell
Published 2024-12-01
Article -
20
Autologous stem cell transplant in fit patients with refractory or early relapsed diffuse large B-cell lymphoma that responded to salvage chemotherapy by Aung M. Tun, Yucai Wang, Seth Maliske, Ivana Micallef, David J. Inwards, Thomas M. Habermann, Luis Porrata, Jonas Paludo, Jose Villasboas Bisneto, Allison Rosenthal, Mohamed A Kharfan-Dabaja, Stephen M. Ansell, Grzegorz S. Nowakowski, Umar Farooq, Patrick B. Johnston
Published 2024-01-01
Article